Astringent Market
Astringent Market Size, Share & Trends Analysis Report by Type (Thrombin-Based Astringent, Oxidized Regenerated Cellulose-Based Astringent, Combination Astringent, Gelatin-Based Astringent, and Collagen-Based Astringent), and by Application (Hospitals & Surgical Centers, Dental & Outpatient Clinics, and Nursing Homes & Long-Term Care), Forecast Period (2026-2035)
Industry Overview
Astringent market was valued at $3.04 billion in 2025 and is projected to reach $5.52 billion by 2035, growing at a CAGR of 6.2% during the forecast period (2026-2035). The global astringent market is growing due to the increasing demand for effective surgical hemostatic solutions across healthcare settings. Rising numbers of surgical procedures in hospitals and outpatient clinics have driven the adoption of advanced astringent products, particularly thrombin-based and oxidized regenerated cellulose agents, which offer reliable blood-clotting performance. Additionally, the expansion of minimally invasive surgeries has heightened the need for fast-acting, absorbable hemostats that reduce procedural complications and recovery time. Growing awareness among healthcare providers regarding patient safety and perioperative efficiency further supports market uptake.
Market Dynamics
Shift Toward Absorbable and Biocompatible Astringents
The global astringent market is witnessing a clear shift toward absorbable and biocompatible products used in surgical settings. Hospitals and surgical centers increasingly prefer collagen-based and gelatin-based astringents due to their predictable absorption profiles and reduced need for follow-up intervention. This trend is supported by stricter clinical protocols that prioritize patient safety and lower postoperative complication risks. As procedure volumes rise, especially in general and orthopedic surgeries, demand for materials that integrate safely with tissue continues to strengthen. This transition directly supports steady volume growth across core product types.
Rising Use in Dental and Outpatient Procedures
An emerging trend in the global astringent market is the expanding use of astringents in dental and outpatient clinics. Growth in minor surgical and dental procedures has increased demand for easy-to-handle, fast-acting hemostatic solutions suitable for non-hospital settings. Thrombin-based and combination astringents are gaining traction in these environments due to their effectiveness and procedural efficiency. The gradual shift of select procedures away from large hospitals toward outpatient facilities further supports this trend. As a result, application-based demand is becoming more diversified beyond traditional inpatient care.
Market Segmentation
- Based on the type, the market is segmented into thrombin-based astringent, oxidized regenerated cellulose-based astringent, combination astringent, gelatin-based astringent, and collagen-based astringent.
- Based on the application, the market is segmented into hospitals & surgical centers, dental & outpatient clinics, and nursing homes & long-term care.
Thrombin-Based Astringent Segment Is Driving Type-Based Market Expansion
The thrombin-based astringent segment represents a leading share within the global astringent market due to its direct role in accelerating blood coagulation during surgical procedures. Its consistent performance across a wide range of surgeries has made it a preferred choice in hospitals and surgical centers. Growing surgical volumes, particularly in cardiovascular and orthopedic procedures, continue to support steady demand for thrombin-based products. The segment also benefits from clinician familiarity and established clinical protocols that favor thrombin use. As a result, this sub-segment remains a core revenue contributor within the overall market structure.
Hospitals & Surgical Centers Segment Anchors Application-Based Demand
Hospitals and Surgical Centers form the largest application sub-segment in the global astringent market, driven by high procedure volumes and complex surgical requirements. These settings account for sustained usage of multiple astringent types, including oxidized regenerated cellulose and combination astringents. The concentration of major surgical interventions in hospital environments ensures repeat and large-volume consumption of hemostatic agents. Ongoing expansion of surgical infrastructure in both developed and emerging markets further reinforces this demand pattern. Consequently, this application segment continues to anchor market growth and revenue stability.
Regional Outlook
The global astringent market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Remains the Leading Region in the Global Astringent Market
North America holds the leading position in the global astringent market, supported by a high volume of surgical procedures and a well-established healthcare infrastructure. Hospitals and surgical centers across the US and Canada show strong adoption of thrombin-based and oxidized regenerated cellulose-based astringents due to standardized surgical protocols. The region benefits from the strong presence of major manufacturers and consistent product availability across clinical settings. Ongoing investment in surgical innovation and patient safety further sustains demand for advanced hemostatic solutions. As a result, North America continues to account for a significant share of global market revenue.
Asia-Pacific Is the Fastest Growing Region in the Global Astringent Market
Asia-Pacific represents the fastest-growing region in the global astringent market, driven by expanding healthcare access and rising surgical volumes across emerging economies. Countries such as China and India are witnessing increased adoption of astringents in hospitals and outpatient clinics as procedural capacity improves. Growth in private healthcare facilities and gradual modernization of surgical practices are supporting demand for gelatin-based and collagen-based products. The region is also seeing stronger penetration of cost-effective astringent solutions to meet high patient volumes. These factors collectively position Asia-Pacific as the key growth engine for the global market.
Market Players Outlook
The major companies operating in the global astringent market include B. Braun Melsungen AG, Baxter International Inc., Johnson & Johnson Services, Inc., Medtronic plc, Pfizer Inc., among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In April 2025, Baxter International launched a new version of its Hemopatch Sealing Hemostat that can be stored at room temperature, enhancing accessibility in operating rooms. This evolution, developed in collaboration with surgeons, eliminates the need for refrigeration, ensuring the product is readily available for bleeding control and tissue sealing. The product is now available across Europe.
- In May 2025, Merit Medical Systems acquired Biolife Delaware, a maker of patented hemostatic devices StatSeal and WoundSeal. Biolife is now a wholly-owned subsidiary. This acquisition aims to expand Merit's product offerings to simplify and improve post-procedure care for clinicians.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global astringent market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Astringent Market Sales Analysis – Type | Application ($ Million)
- Astringent Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Astringent Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Astringent Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Astringent Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Astringent Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Astringent Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Astringent Market Revenue and Share by Manufacturers
- Astringent Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Braun Melsungen AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Baxter International Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Johnson & Johnson Services, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Medtronic plc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Pfizer Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Braun Melsungen AG
- Key Company Analysis
- Global Astringent Market Sales Analysis by Type ($ Million)
- Thrombin-Based Astringent
- Oxidized Regenerated Cellulose-Based Astringent
- Combination Astringent
- Gelatin-Based Astringent
- Collagen-Based Astringent
- Global Astringent Market Sales Analysis by Application ($ Million)
- Hospitals & Surgical Centers
- Dental & Outpatient Clinics
- Nursing Homes & Long-Term Care
- Regional Analysis
- North American Astringent Market Sales Analysis – Type | Application | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Astringent Market Sales Analysis – Type | Application | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Astringent Market Sales Analysis – Type | Application | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Astringent Market Sales Analysis – Type | Application | Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Advanced Medical Solutions Group plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Aegis Lifesciences Private Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Anika Therapeutics, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Braun Melsungen AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Baxter International Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BD (Becton, Dickinson and Company)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- CSL Behring GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- CryoLife, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Equimedical B.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Gelita Medical GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hemostasis LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Integra LifeSciences Holdings Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Johnson & Johnson Services, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Marine Polymer Technologies, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medtronic plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pfizer Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Teleflex Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vascular Solutions, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Z?Medica, LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Advanced Medical Solutions Group plc
1. Global Astringent Market Research and Analysis by Type, 2025–2035 ($ Million)
2. Global Thrombin-Based Astringent Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Oxidized Regenerated Cellulose-Based Astringent Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Combination Astringent Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Gelatin-Based Astringent Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Collagen-Based Astringent Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Astringent Market Research and Analysis by Application, 2025–2035 ($ Million)
8. Global Astringent in Hospitals & Surgical Centers Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Astringent in Dental & Outpatient Clinics Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Astringent in Nursing Homes & Long-Term Care Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Astringent Market Research and Analysis by Region, 2025–2035 ($ Million)
12. North American Astringent Market Research and Analysis by Country, 2025–2035 ($ Million)
13. North American Astringent Market Research and Analysis by Type, 2025–2035 ($ Million)
14. North American Astringent Market Research and Analysis by Application, 2025–2035 ($ Million)
15. European Astringent Market Research and Analysis by Country, 2025–2035 ($ Million)
16. European Astringent Market Research and Analysis by Type, 2025–2035 ($ Million)
17. European Astringent Market Research and Analysis by Application, 2025–2035 ($ Million)
18. Asia-Pacific Astringent Market Research and Analysis by Country, 2025–2035 ($ Million)
19. Asia-Pacific Astringent Market Research and Analysis by Type, 2025–2035 ($ Million)
20. Asia-Pacific Astringent Market Research and Analysis by Application, 2025–2035 ($ Million)
21. Rest of the World Astringent Market Research and Analysis by Region, 2025–2035 ($ Million)
22. Rest of the World Astringent Market Research and Analysis by Type, 2025–2035 ($ Million)
23. Rest of the World Astringent Market Research and Analysis by Application, 2025–2035 ($ Million)
1. Global Astringent Market Share by Type, 2025 vs 2035 (%)
2. Global Thrombin-Based Astringent Market Share by Region, 2025 vs 2035 (%)
3. Global Oxidized Regenerated Cellulose-Based Astringent Market Share by Region, 2025 vs 2035 (%)
4. Global Combination Astringent Market Share by Region, 2025 vs 2035 (%)
5. Global Gelatin-Based Astringent Market Share by Region, 2025 vs 2035 (%)
6. Global Collagen-Based Astringent Market Share by Region, 2025 vs 2035 (%)
7. Global Astringent Market Share by Application, 2025 vs 2035 (%)
8. Global Astringent in Hospitals & Surgical Centers Market Share by Region, 2025 vs 2035 (%)
9. Global Astringent in Dental & Outpatient Clinics Market Share by Region, 2025 vs 2035 (%)
10. Global Astringent in Nursing Homes & Long-Term Care Market Share by Region, 2025 vs 2035 (%)
11. Global Astringent Market Research and Analysis by Region, 2025–2035 ($ Million)
12. US Astringent Market Size, 2025–2035 ($ Million)
13. Canada Astringent Market Size, 2025–2035 ($ Million)
14. UK Astringent Market Size, 2025–2035 ($ Million)
15. France Astringent Market Size, 2025–2035 ($ Million)
16. Germany Astringent Market Size, 2025–2035 ($ Million)
17. Italy Astringent Market Size, 2025–2035 ($ Million)
18. Spain Astringent Market Size, 2025–2035 ($ Million)
19. Russia Astringent Market Size, 2025–2035 ($ Million)
20. Rest of Europe Astringent Market Size, 2025–2035 ($ Million)
21. India Astringent Market Size, 2025–2035 ($ Million)
22. China Astringent Market Size, 2025–2035 ($ Million)
23. Japan Astringent Market Size, 2025–2035 ($ Million)
24. South Korea Astringent Market Size, 2025–2035 ($ Million)
25. Australia and New Zealand Astringent Market Size, 2025–2035 ($ Million)
26. ASEAN Economies Astringent Market Size, 2025–2035 ($ Million)
27. Rest of Asia-Pacific Astringent Market Size, 2025–2035 ($ Million)
28. Latin America Astringent Market Size, 2025–2035 ($ Million)
29. Middle East and Africa Astringent Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Astringent Market in 2025 is estimated to be around $3.04 billion.
North America holds the largest share in the Astringent Market.
Leading players in the Astringent Market include B. Braun Melsungen AG, Baxter International Inc., Johnson & Johnson Services, Inc., Medtronic plc, Pfizer Inc., among others.
The Astringent Market is expected to grow at a CAGR of 6.2% from 2026 to 2035.
The Astringent Market growth is driven by increasing demand for skincare products and rising consumer focus on personal grooming and acne care solutions.
